Clinical Trial Update: Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Pegasys (pegylated interferon alfa-2a) plus entecavir versus entecavir alone for Hepatitis Be antigen-positive chronic hepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN